Adcetris, INN brentuximab vedotin

Amvuttra, INN vutrisiran

Bimzelx, INN Bimekizumab

Calquence CLL, INN acalabrutinib

Calquence MCL, INN acalabrutinib

Enhertu, INN trastuzumab deruxtecan

Hemlibra, INN Emicizumab

Infinzi NSCLC neoadj.+adj., INN durvalumab

Imfinzi LS-SCLC, INN durvalumab

Imfinzi + Lynparza, INN durvalumab + olaparib

Imjudo + Imfinzi NSCLC, INN tramelimumab + durvalumab

Keytruda LACC, INN pembrolizumab

Nilemdo, INN Bempedoic acid

Nubeqa, INN darolutamide

Nustendi, INN Bempedoic acid, еzetimibe

Opdivo 1L UC, INN Nivolumab

Opdivo CRC-dMMR 1L, INN Nivolumab

Opdivo CRC-dMMR 2+L, INN Nivolumab

Rinvoq GCA, INN Upadacitinib

Rybrevant NSCLC 19, 21, INN amivantamab

Rybrevant NSCLC 20, INN amivantamab

Tagrisso (exon 19, 21; 1L), INN osimertinib

Tagrisso (exon 19, 21; 2L), INN osimertinib

Talzenna, INN Talazoparib

Tecentriq, INN Atezolizumab

Tepkinly, INN epcoritamab

Tremfya CD, INN guselkumab

Tremfya UC, INN guselkumab

Triumeq, INN Dolutegravir, Abacavir, Lamivudine

Keytruda 1L EC, INN pembrolizumab

Keytruda RCC, INN pembrolizumab

Libtayo CC, INN cemiplimab

Libtayo laBCC,mBCC, INN cemiplimab

Libtayo NSCLC, INN cemiplimab